Format

Send to

Choose Destination
Int J Mol Sci. 2020 Mar 11;21(6). pii: E1915. doi: 10.3390/ijms21061915.

Electrohypersensitivity as a Newly Identified and Characterized Neurologic Pathological Disorder: How to Diagnose, Treat, and Prevent It.

Author information

1
Association for Research Against Cancer (ARTAC), 57/59 rue de la Convention, 75015 Paris, France.
2
European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium.
3
Department of Cancer Clinical Research, Paris V University Hospital, 75005 Paris, France.

Abstract

Since 2009, we built up a database which presently includes more than 2000 electrohypersensitivity (EHS) and/or multiple chemical sensitivity (MCS) self-reported cases. This database shows that EHS is associated in 30% of the cases with MCS, and that MCS precedes the occurrence of EHS in 37% of these EHS/MCS-associated cases. EHS and MCS can be characterized clinically by a similar symptomatic picture, and biologically by low-grade inflammation and an autoimmune response involving autoantibodies against O-myelin. Moreover, 80% of the patients with EHS present with one, two, or three detectable oxidative stress biomarkers in their peripheral blood, meaning that overall these patients present with a true objective somatic disorder. Moreover, by using ultrasonic cerebral tomosphygmography and transcranial Doppler ultrasonography, we showed that cases have a defect in the middle cerebral artery hemodynamics, and we localized a tissue pulsometric index deficiency in the capsulo-thalamic area of the temporal lobes, suggesting the involvement of the limbic system and the thalamus. Altogether, these data strongly suggest that EHS is a neurologic pathological disorder which can be diagnosed, treated, and prevented. Because EHS is becoming a new insidious worldwide plague involving millions of people, we ask the World Health Organization (WHO) to include EHS as a neurologic disorder in the international classification of diseases.

KEYWORDS:

O-myelin; electrohypersensibility; electromagnetic fields; extremely low frequency; histamine; inflammation; melatonin; multiple chemical sensitivity; neurologic disease; oxidative stress; radiofrequency

PMID:
32168876
DOI:
10.3390/ijms21061915
Free full text

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI)
Loading ...
Support Center